Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination medication containing pantoprazole, amoxicillin, and clarithromycin. Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production. Amoxicillin and clarithromycin are antibiotics used to eradicate *Helicobacter pylori* (H. pylori) infection.
## Primary Indications
Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The typical adult dosage is one kit taken twice daily for 10-14 days. Each kit contains:
* Pantoprazole 40 mg delayed-release tablet
* Amoxicillin 500 mg capsule
* Clarithromycin 500 mg tablet
Patients should take all components of the kit together, twice daily, for the prescribed duration.
## Pediatric Dosing
No established pediatric dosing is available for Sompraz HP.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for pantoprazole. Dose adjustments for amoxicillin and clarithromycin may be necessary based on the degree of renal impairment. Consult specific prescribing information for amoxicillin and clarithromycin.
* **Hepatic Impairment:** No dose adjustment is typically required for pantoprazole. Consider reduced doses or longer intervals for clarithromycin in patients with severe hepatic impairment.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of hypersensitivity to penicillin or cephalosporins (for amoxicillin).
* History of cholestatic jaundice/hepatic dysfunction associated with prior macrolide exposure (for clarithromycin).
* Severe renal impairment (for clarithromycin, typically CrCl < 30 mL/min).
* Concurrent use with rifabutin, cisapride, pimozide, and ergotamine alkaloids (for clarithromycin).
## Adverse Effects
Common adverse effects may include diarrhea, nausea, headache, abdominal pain, rash, and taste disturbances. More serious adverse effects can include severe allergic reactions, Clostridioides difficile-associated diarrhea, liver dysfunction, and QT prolongation (clarithromycin).
## Key Drug Interactions
* **Pantoprazole:** Can affect the absorption of drugs requiring acidic environments (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May increase levels of methotrexate.
* **Amoxicillin:** May decrease the effectiveness of oral contraceptives. Probenecid may increase and prolong blood levels of amoxicillin.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase plasma concentrations of numerous drugs metabolized by this enzyme, including statins, calcium channel blockers, warfarin, and certain immunosuppressants. May interact with colchicine, increasing toxicity.
## Monitoring
* Monitor for signs and symptoms of *H. pylori* eradication (e.g., symptom improvement, stool antigen testing post-treatment).
* Monitor for adverse effects, including diarrhea, rash, and signs of liver dysfunction.
* Monitor drug interactions, especially with clarithromycin's CYP3A4 inhibition.
## Clinical Pearls
* Ensure complete the full 10-14 day course of therapy, even if symptoms improve earlier.
* Administer the pantoprazole component at least 30 minutes before a meal.
* Patient education regarding potential side effects and drug interactions is crucial.
* Consider patient allergies to penicillin and macrolides before prescribing.
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for clinical judgment. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.
